132 results
Page 5 of 7
425
zrnbzw6ezcl fvr
30 Apr 21
Business combination disclosure
10:46am
8-K
vk9kasuetog8tu
30 Apr 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
10:45am
425
0hbg2teifi
27 Apr 21
Business combination disclosure
8:40pm
PRE 14A
2nj8 w96ni7ubg
29 Mar 21
Preliminary proxy
7:34am
S-4/A
EX-10.23
odteepj1ipr2iti 0y
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
EX-10.22
9fr4ovyzanprjlv
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
i1iedx9et962m c1
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
EX-10.27
agxcrut0xz2jaobq
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
CORRESP
ymx8wegdto5va 5bw
29 Mar 21
Correspondence with SEC
12:00am
UPLOAD
mi202bbxjl36
22 Feb 21
Letter from SEC
12:00am
425
m43uaff
11 Feb 21
Business combination disclosure
6:27am
S-4
qu5x5eg 2ic
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-10.1
b7h756u ey
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
8-K
EX-2.1
lnwona0itql zj2c7kqe
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am